These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 29024942)
1. Loss of Myosin Vb in colorectal cancer is a strong prognostic factor for disease recurrence. Letellier E; Schmitz M; Ginolhac A; Rodriguez F; Ullmann P; Qureshi-Baig K; Frasquilho S; Antunes L; Haan S Br J Cancer; 2017 Nov; 117(11):1689-1701. PubMed ID: 29024942 [TBL] [Abstract][Full Text] [Related]
2. Myosin Vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease. Knowles BC; Roland JT; Krishnan M; Tyska MJ; Lapierre LA; Dickman PS; Goldenring JR; Shub MD J Clin Invest; 2014 Jul; 124(7):2947-62. PubMed ID: 24892806 [TBL] [Abstract][Full Text] [Related]
3. Rab GTPase-Myo5B complexes control membrane recycling and epithelial polarization. Roland JT; Bryant DM; Datta A; Itzen A; Mostov KE; Goldenring JR Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2789-94. PubMed ID: 21282656 [TBL] [Abstract][Full Text] [Related]
4. Myosin Vb as a tumor suppressor gene in intestinal cancer. Cartón-García F; Brotons B; Anguita E; Dopeso H; Tarragona J; Nieto R; García-Vidal E; Macaya I; Zagyva Z; Dalmau M; Sánchez-Martín M; van Ijzendoorn SCD; Landolfi S; Hernandez-Losa J; Schwartz S; Matias-Guiu X; Ramón Y Cajal S; Martínez-Barriocanal Á; Arango D Oncogene; 2022 Dec; 41(49):5279-5288. PubMed ID: 36316444 [TBL] [Abstract][Full Text] [Related]
5. MYO5B mutations in pheochromocytoma/paraganglioma promote cancer progression. Tomić TT; Olausson J; Rehammar A; Deland L; Muth A; Ejeskär K; Nilsson S; Kristiansson E; Wassén ON; Abel F PLoS Genet; 2020 Jun; 16(6):e1008803. PubMed ID: 32511227 [TBL] [Abstract][Full Text] [Related]
6. An overview and online registry of microvillus inclusion disease patients and their MYO5B mutations. van der Velde KJ; Dhekne HS; Swertz MA; Sirigu S; Ropars V; Vinke PC; Rengaw T; van den Akker PC; Rings EH; Houdusse A; van Ijzendoorn SC Hum Mutat; 2013 Dec; 34(12):1597-605. PubMed ID: 24014347 [TBL] [Abstract][Full Text] [Related]
7. The Actin-Based Motor Myosin Vb Is Crucial to Maintain Epidermal Barrier Integrity. Reynier M; Allart S; Goudounèche D; Moga A; Serre G; Simon M; Leprince C J Invest Dermatol; 2019 Jul; 139(7):1430-1438. PubMed ID: 30660668 [TBL] [Abstract][Full Text] [Related]
8. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer. Stanisavljević L; Myklebust MP; Leh S; Dahl O Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662 [TBL] [Abstract][Full Text] [Related]
9. Loss of MYO5B expression deregulates late endosome size which hinders mitotic spindle orientation. Leng C; Overeem AW; Cartón-Garcia F; Li Q; Klappe K; Kuipers J; Cui Y; Zuhorn IS; Arango D; van IJzendoorn SCD PLoS Biol; 2019 Nov; 17(11):e3000531. PubMed ID: 31682603 [TBL] [Abstract][Full Text] [Related]
10. Functional characterization of mutations in the myosin Vb gene associated with microvillus inclusion disease. Szperl AM; Golachowska MR; Bruinenberg M; Prekeris R; Thunnissen AM; Karrenbeld A; Dijkstra G; Hoekstra D; Mercer D; Ksiazyk J; Wijmenga C; Wapenaar MC; Rings EH; van IJzendoorn SC J Pediatr Gastroenterol Nutr; 2011 Mar; 52(3):307-13. PubMed ID: 21206382 [TBL] [Abstract][Full Text] [Related]
11. Inactivation of MYO5B promotes invasion and motility in gastric cancer cells. Dong W; Chen X; Chen P; Yue D; Zhu L; Fan Q Dig Dis Sci; 2012 May; 57(5):1247-52. PubMed ID: 22134786 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer. Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630 [TBL] [Abstract][Full Text] [Related]
13. A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer. Sho S; Court CM; Winograd P; Russell MM; Tomlinson JS J Surg Oncol; 2017 Dec; 116(8):996-1004. PubMed ID: 28767131 [TBL] [Abstract][Full Text] [Related]
14. Monoamine Oxidase B Expression Correlates with a Poor Prognosis in Colorectal Cancer Patients and Is Significantly Associated with Epithelial-to-Mesenchymal Transition-Related Gene Signatures. Yang YC; Chien MH; Lai TC; Su CY; Jan YH; Hsiao M; Chen CL Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316576 [TBL] [Abstract][Full Text] [Related]
15. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer. Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692 [TBL] [Abstract][Full Text] [Related]
17. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer. Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853 [TBL] [Abstract][Full Text] [Related]
18. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer. Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443 [TBL] [Abstract][Full Text] [Related]
19. Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-Lined Inclusions and Alterations in Sodium Transporters. Engevik AC; Coutts AW; Kaji I; Rodriguez P; Ongaratto F; Saqui-Salces M; Medida RL; Meyer AR; Kolobova E; Engevik MA; Williams JA; Shub MD; Carlson DF; Melkamu T; Goldenring JR Gastroenterology; 2020 Jun; 158(8):2236-2249.e9. PubMed ID: 32112796 [TBL] [Abstract][Full Text] [Related]
20. A Functional Relationship Between UNC45A and MYO5B Connects Two Rare Diseases With Shared Enteropathy. Li Q; Zhou Z; Sun Y; Sun C; Klappe K; van IJzendoorn SCD Cell Mol Gastroenterol Hepatol; 2022; 14(2):295-310. PubMed ID: 35421597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]